MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a suspension of tiny crystals. Once under the skin, the crystals assemble into a drug ...
With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved Novartis AG’s (NYSE:NVS) oral Fabhalta (iptacopan) for ...
The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...
Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.
Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...
This advancement will improve prehospital patient care by providing EMS professionals with an intuitive, real-time solution ...
To learn more about this medication, see this in-depth Zepbound article. The following table shows the basics of Zepbound’s dosing schedule when the drug is prescribed for weight loss.
But how much can you earn on the money you’re stashing away? A savings calculator is a great tool to help you see exactly how much your dollar will earn at different interest rates. That can ...
However, current teicoplanin treatment is challenging due to relatively low and variable concentrations under standard dosage regimens ... who received any special treatment that may affect drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results